Recurrence of Subdural Haematoma in a Population-Based Cohort – Risks and Predictive Factors

Abstract

ObjectivesTo estimate the risks of and identify predictors for recurrent subdural haematoma in surgically and conservatively treated patients.MethodsThe cohort comprised all individuals diagnosed with a first-time subdural hematoma in Denmark 1996–2011. Information on potential predictors was retrieved from the Danish health registers. Cumulative recurrence risks were estimated using the Aalen-Johansen estimator. Rate ratios (RR) were estimated using Poisson regression.ResultsAmong 10,158 individuals with a subdural hematoma, 1,555 had a recurrent event. The cumulative risk of recurrent subdural hematoma was 9% at 4 weeks after the primary bleeding, increasing to and stabilising at 14% after one year. Predictors associated with recurrence were: Male sex (RR 1.60, 95% CI:1.43–1.80), older age (>70 years compared to 20–49 years; RR 1.41, 95% CI: 1.21–1.65), alcohol addiction (RR 1.20, 95% CI:1.04–1.37), surgical treatment (RR 1.76, 95% CI:1.58–1.96), trauma diagnoses (RR 1.14, 95% CI:1.03–1.27), and diabetes mellitus (RR 1.40, 95% CI:1.11–1.74). Out of a selected combination of risk factors, the highest cumulative 1-year recurrence risks for subdural hematoma of 25% (compared to 14% for all patients) was found in surgically treated males with diabetes mellitus.ConclusionsThe recurrence risk of subdural hematoma is largely limited to the first year. Patient characteristics including co-morbidities greatly influence the recurrence risk of SDH, suggesting that individualized prognostic guidance and follow-up is needed.

Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption

“…As the aging population continues to grow, CSDH prevalence is increasing, becoming one of the most common cranial neurosurgical conditions and a significant public health problem 1. Furthermore, traditional treatments, including surgical evacuation, have proven disappointing with a high incidence of recurrence at 1 year, averaging approximately 15% 2…”

Evidence for the Use of Tranexamic Acid in Subarachnoid and Subdural Hemorrhage: A Systematic Review

“…20,21 SDHs have a high recurrence rate, with one study reporting a cumulative recurrence risk of 14% within the first year. 22 TXA could potentially reduce the SDH recurrence rate 23 and be used as nonsurgical treatment for chronic SDH. 24,25 Thus, the aim of this systematic review is to summarize and discuss the evidence for the use of TXA in patients with SAH or SDH.…”

Acute Traumatic Subdural Hematoma among the Elderly: Reducing Readmission

“…The use of anticoagulant therapy and the population's multiple comorbid conditions (age, dementia diabetes, chronic hepatic disease, to name a few) are frequently implicated in its recurrence. 3,4 However, the use of anticoagulant therapy in our patients did not correlate with the readmission rate.…”

“…Recurrence of TSDH occurs largely within the first year after the initial incidence of TSDH, estimated at 14 per cent. 4 In our study, we elected to concentrate on the first six months after discharge since the majority of our readmitted patients are in a higher age group (mean 4 73 years, standard deviation 4 16.87, range 4 30-90).…”